Should further studies of chemotherapy be carried out in pancreatic cancer? (Q72084799)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7686019%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

editorial

0 references

title

Should further studies of chemotherapy be carried out in pancreatic cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7686019%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

I. Taylor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7686019

18 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7686019

18 August 2024

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7686019%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 October 2019

https://api.elsevier.com/content/article/PII:S0959804905802904?httpAccept=text/xml

1 reference

10.1016/S0959-8049(05)80290-4

DOI

https://api.crossref.org/works/10.1016/S0959-8049(05)80290-4

https://api.elsevier.com/content/article/PII:S0959804905802904?httpAccept=text/plain

18 August 2024

1 reference

10.1016/S0959-8049(05)80290-4

DOI

https://api.crossref.org/works/10.1016/S0959-8049(05)80290-4

European Journal of Cancer

18 August 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7686019%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

29A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7686019%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7686019%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

1076-1078

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7686019%20AND%20SRC:MED&resulttype=core&format=json

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

23 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980290-4

7 January 2021

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980290-4

7 January 2021

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980290-4

7 January 2021

Surgical palliation for pancreatic cancer: developments during the past two decades

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980290-4

7 January 2021

Current status of chemotherapy for advanced pancreatic and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980290-4

7 January 2021

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980290-4

7 January 2021

Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980290-4

7 January 2021

Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980290-4

7 January 2021

10.1016/S0959-8049(05)80290-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7686019%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference